Paper21102461
Treatment of cerebral ischemia by disrupting ischemia-induced interaction of nNOS with PSD-95.
Zhou L and 9 others. Nat Med, 2010. Cited by 365 papers, by iCite.
Cite this record
ConductScience Library. Treatment of cerebral ischemia by disrupting ischemia-induced interaction of nNOS with PSD-95. Papers, record 21102461. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/21102461
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Treatment of cerebral ischemia by disrupting ischemia-induced interaction of nNOS with PSD-95.
- PubMed
Topics22
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Brain Ischemia | Major topic |
| Intracellular Signaling Peptides and Proteins | Major topic |
| Membrane Proteins | Major topic |
| Neuroprotective Agents | Major topic |
| Nitric Oxide Synthase Type I | Major topic |
| Oligonucleotides, Antisense | Major topic |
| Signal Transduction | Major topic |
| Stroke | Major topic |
| Analysis of Variance | |
| Animals | |
| Biological Transport | |
| Cell Death | |
| Disks Large Homolog 4 Protein | |
| Glutamic Acid | |
| Guanylate Kinases | |
| Immunoprecipitation | |
| Infarction, Middle Cerebral Artery | |
| Mice | |
| Microscopy, Confocal | |
| Molecular Structure | |
| Rats | |
| Receptors, N-Methyl-D-Aspartate |
Source PubMed
Trials4
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record | Source |
|---|---|---|---|---|
| NCT05849805 | Y-3 Injection Through Skull Bone Marrow in the Treatment of Acute Malignant Middle Cerebral Artery Infarction (SOLUTION) | Background | ClinicalTrials.gov | |
| NCT06429384 | Y-3 Injection in the Treatment of Acute Ischemic Stroke Phase II Clinical Trial | Results | ClinicalTrials.gov | |
| NCT06517173 | Y-3 for Injection in the Treatment of Acute Ischemic Stroke | Background | ClinicalTrials.gov | |
| NCT07514949 | The Feasibility and Safety of RK-4 Injection Bypassing Blood-brain Barrier in the Treatment of Acute Large Hemispheric Infarction Using Intracalvariosseous Injection Device | Background | ClinicalTrials.gov |
Comments and corrections2
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers | Source |
|---|---|---|---|---|
| Comment in | 21135846 | Fashioning drugs for stroke. | https://conductscience.org/library/papers/21135846 | PubMed |
| Comment in | 21391317 | Stroke: Disruption of the nNOS–PSD-95 complex is neuroprotective in models of cerebral ischemia. | https://conductscience.org/library/papers/21391317 | PubMed |
References34
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 14615633 | Selective Enrichment of Membrane Proteins by Partition Phase Separation for Proteomic Studies. | J Biomed Biotechnol | 2003 | https://conductscience.org/library/papers/14615633 | PubMed |
| 2 | 8625413 | Interaction of nitric oxide synthase with the postsynaptic density protein PSD-95 and alpha1-syntrophin mediated by PDZ domains. | Cell | 1996 | https://conductscience.org/library/papers/8625413 | PubMed |
| 3 | 11031113 | Formation of nNOS/PSD-95 PDZ dimer requires a preformed beta-finger structure from the nNOS PDZ domain. | J Mol Biol | 2000 | https://conductscience.org/library/papers/11031113 | PubMed |
| 4 | 7510784 | Subcellular localization and characterization of neuronal nitric oxide synthase. | J Neurochem | 1994 | https://conductscience.org/library/papers/7510784 | PubMed |
| 5 | 14659087 | Bringing order to the glutamate chaos in schizophrenia. | Neuron | 2003 | https://conductscience.org/library/papers/14659087 | PubMed |
| 6 | 12399596 | Treatment of ischemic brain damage by perturbing NMDA receptor- PSD-95 protein interactions. | Science | 2002 | https://conductscience.org/library/papers/12399596 | PubMed |
| 7 | 19538708 | Abnormal social behavior, hyperactivity, impaired remote spatial memory, and increased D1-mediated dopaminergic signaling in neuronal nitric oxide synthase knockout mice. | Mol Brain | 2009 | https://conductscience.org/library/papers/19538708 | PubMed |
| 8 | 17855605 | PDZ protein interactions underlying NMDA receptor-mediated excitotoxicity and neuroprotection by PSD-95 inhibitors. | J Neurosci | 2007 | https://conductscience.org/library/papers/17855605 | PubMed |
| 9 | 19298861 | Neuronal nitric oxide synthase: structure, subcellular localization, regulation, and clinical implications. | Nitric Oxide | 2009 | https://conductscience.org/library/papers/19298861 | PubMed |
| 10 | 12403981 | NMDA receptor pathways as drug targets. | Nat Neurosci | 2002 | https://conductscience.org/library/papers/12403981 | PubMed |
| 11 | 11158630 | Brain serotonin dysfunction accounts for aggression in male mice lacking neuronal nitric oxide synthase. | Proc Natl Acad Sci U S A | 2001 | https://conductscience.org/library/papers/11158630 | PubMed |
| 12 | 16359918 | Glutamate-based therapeutic approaches: clinical trials with NMDA antagonists. | Curr Opin Pharmacol | 2006 | https://conductscience.org/library/papers/16359918 | PubMed |
| 13 | 10617118 | Altered interaction between PSD-95 and the NMDA receptor following transient global ischemia. | J Neurochem | 2000 | https://conductscience.org/library/papers/10617118 | PubMed |
| 14 | 15052409 | Molecular mechanisms of glutamate-dependent neurodegeneration in ischemia and traumatic brain injury. | Cell Mol Life Sci | 2004 | https://conductscience.org/library/papers/15052409 | PubMed |
| 15 | 14619404 | Therapeutic N-methyl-D-aspartate receptor antagonists: will reality meet expectation? | Curr Opin Investig Drugs | 2003 | https://conductscience.org/library/papers/14619404 | PubMed |
| 16 | 19342837 | Emergent cerebrovascular disease risk factor weighting: is transient ischemic attack an imminent threat? | Cerebrovasc Dis | 2009 | https://conductscience.org/library/papers/19342837 | PubMed |
| 17 | 2643202 | Reversible middle cerebral artery occlusion without craniectomy in rats. | Stroke | 1989 | https://conductscience.org/library/papers/2643202 | PubMed |
| 18 | 19404260 | Mechanism of differential control of NMDA receptor activity by NR2 subunits. | Nature | 2009 | https://conductscience.org/library/papers/19404260 | PubMed |
| 19 | 10623522 | Solution structure and backbone dynamics of the second PDZ domain of postsynaptic density-95. | J Mol Biol | 2000 | https://conductscience.org/library/papers/10623522 | PubMed |
| 20 | 9466415 | Subcellular localization of the neuronal isoform of nitric oxide synthase in the rat brain: a critical evaluation. | Neuroscience | 1998 | https://conductscience.org/library/papers/9466415 | PubMed |
Cited by204
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 365 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42940120 | The Glymphatic System in Traumatic Brain Injury, Subarachnoid Hemorrhage, and Neurodegeneration: A Unifying Neurobiological Framework. | Biomedicines | 2026 | https://conductscience.org/library/papers/42940120 | PubMed |
| 42575968 | Protein-protein interaction-mediated signaling networks in ischemic stroke: from molecular mechanisms to therapeutic strategies. | Acta Pharmacol Sin | 2026 | https://conductscience.org/library/papers/42575968 | PubMed |
| 42278518 | ZL006 Treatment Reduces Inflammation, Oxidative Stress, and Brain Aβ1-42 Accumulation and Rescues the Loss of PSD95 Synaptic Marker in Familial Alzheimer's Disease-Associated psen1-Deficient Zebrafish Model. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42278518 | PubMed |
| 41814472 | Astrocytic Mitochondria Transplantation Rescues Neuron Loss and Dendritic Injuries in Acute Cerebral Ischemic Stroke Mouse Model by Flexibly Regulating Mitochondria Dynamics. | Ann Neurol | 2026 | https://conductscience.org/library/papers/41814472 | PubMed |
| 41756238 | Review of neuroprotective potential of natural products against hypoxia-induced neuronal injury. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/41756238 | PubMed |
| 41730997 | A modified tail suspension test for the assessment of behavioral despair in mice after stroke. | Acta Pharmacol Sin | 2026 | https://conductscience.org/library/papers/41730997 | PubMed |
| 41496301 | Therapeutic potential of nitric oxide and its donors in hemorrhagic and ischemic stroke: a systematic review. | Med Gas Res | 2026 | https://conductscience.org/library/papers/41496301 | PubMed |
| 41463361 | Enduring Effects of Humanin on Mitochondrial Systems in TBI Pathology. | Biomolecules | 2025 | https://conductscience.org/library/papers/41463361 | PubMed |
| 41398232 | Elevated circulation postsynaptic density protein 95 as a potential biomarker for predicting the diagnosis and prognosis of acute cerebral infarction. | BMC Neurol | 2025 | https://conductscience.org/library/papers/41398232 | PubMed |
| 41344725 | Loberamisal for Acute Ischaemic Stroke (LAIS): a multicentre, randomised, double-blind, parallel, placebo-controlled phase III clinical trial. | Stroke Vasc Neurol | 2026 | https://conductscience.org/library/papers/41344725 | PubMed |
| 41218852 | Loberamisal injection for the treatment of acute ischaemic stroke: a multicentre, randomised, double-blind, placebo-controlled phase II clinical trial. | Stroke Vasc Neurol | 2026 | https://conductscience.org/library/papers/41218852 | PubMed |
| 41079784 | Targeting Atf4 for enhanced neuroprotection: Role of quercetin-loaded EVs in ischemic stroke. | J Pharm Anal | 2025 | https://conductscience.org/library/papers/41079784 | PubMed |
| 41049732 | Ischemic stroke and intervention strategies based on the timeline of stroke progression: Review and prospects. | Acta Pharm Sin B | 2025 | https://conductscience.org/library/papers/41049732 | PubMed |
| 40979190 | K739 is preferentially targeted over K725 in the deSUMOylation process of neuronal nitric oxide synthase. | Front Chem | 2025 | https://conductscience.org/library/papers/40979190 | PubMed |
| 40880039 | Multifaceted Role of RIMBP2 in Promoting Hearing in Murine Cochlear Hair Cells. | Neurosci Bull | 2026 | https://conductscience.org/library/papers/40880039 | PubMed |
| 40739212 | Unveiling the role of PSD95 phosphorylation after traumatic brain injury: insights from phosphoproteomic analysis. | BMC Neurol | 2025 | https://conductscience.org/library/papers/40739212 | PubMed |
| 40713246 | Redox modulation of the complement cascade contributes to synapse loss in Alzheimer's disease. | Neurotherapeutics | 2025 | https://conductscience.org/library/papers/40713246 | PubMed |
| 40692378 | A Molecular Recruitment Colocalization Platform for Visualizing Multi-Protein Interactions and Engineering Biomolecular Condensates in Living Cells. | Adv Sci (Weinh) | 2025 | https://conductscience.org/library/papers/40692378 | PubMed |
| 40643722 | Metabolite classification through novel metabolomics framework reveals mechanism underlying the therapeutic effects of PSD95-nNOS blockade for post-stroke depression. | Metabolomics | 2025 | https://conductscience.org/library/papers/40643722 | PubMed |
| 40490524 | Exploring NMDAR pathways in ischemic stroke: implications for neurotoxic and neuroprotective mechanisms and therapeutic strategies. | Naunyn Schmiedebergs Arch Pharmacol | 2025 | https://conductscience.org/library/papers/40490524 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/21102461
GET https://conductscience.org/api/papers/v1/21102461/references?page=2